The global market for Pharmaceutical Unit Dose Package was valued at US$ 32580 million in the year 2024 and is projected to reach a revised size of US$ 51640 million by 2031, growing at a CAGR of 6.9% during the forecast period.
Blister packaging, commonly known as unit dose packaging, is used in the pharmaceutical industry for packaging medicine. In blister packaging, a plastic sheet is thermoformed to form multiple cups or blisters that hold the product.
The pharma primary packaging market is driven by the growing pharmaceutical industry and the increasing focus on drug safety and quality. Pharma primary packaging refers to the materials used to directly contain and protect pharmaceutical products, ensuring their integrity and efficacy throughout their shelf life. The rise in drug development and the need for reliable and compliant packaging solutions contribute to market growth as pharma companies seek packaging that maintains product stability and prevents contamination. Moreover, advancements in packaging technology, such as blister packs and tamper-evident seals, have improved patient safety and medication adherence. However, the market also faces challenges, including the need for sustainable and eco-friendly packaging solutions to address environmental concerns. Additionally, addressing the complexity of regulatory requirements and ensuring compatibility with various drug formulations can pose obstacles for manufacturers. To succeed, companies must focus on research and development to offer innovative and compliant pharma primary packaging, collaborate with pharmaceutical companies to meet specific packaging needs, and address the challenges to meet the increasing demand for safe and reliable packaging solutions in the pharmaceutical industry.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Pharmaceutical Unit Dose Package, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pharmaceutical Unit Dose Package.
The Pharmaceutical Unit Dose Package market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Pharmaceutical Unit Dose Package market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pharmaceutical Unit Dose Package manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Amcor
Constantia Flexibles
Kl枚ckner Pentaplast
Bemis
MeadWestvaco
Tekni-plex
Honeywell
CPH GROUP
Shanghai Haishun
Bilcare
IPS Ariflex
Zhong jin
Carcano Antonio
Aluberg
Goldstonepack
Segment by Type
PVC
Lidding Foils
Cold Form
PVDC
Other
Segment by Application
Capsule Drug
Tablets Drug
Others
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Pharmaceutical Unit Dose Package manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Pharmaceutical Unit Dose Package in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.鈥�
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Pharmaceutical Unit Dose Package 麻豆原创 Overview
1.1 Product Definition
1.2 Pharmaceutical Unit Dose Package by Type
1.2.1 Global Pharmaceutical Unit Dose Package 麻豆原创 Value Comparison by Type (2024 VS 2031)
1.2.2 PVC
1.2.3 Lidding Foils
1.2.4 Cold Form
1.2.5 PVDC
1.2.6 Other
1.3 Pharmaceutical Unit Dose Package by Application
1.3.1 Global Pharmaceutical Unit Dose Package 麻豆原创 Value by Application (2024 VS 2031)
1.3.2 Capsule Drug
1.3.3 Tablets Drug
1.3.4 Others
1.4 Global Pharmaceutical Unit Dose Package 麻豆原创 Size Estimates and Forecasts
1.4.1 Global Pharmaceutical Unit Dose Package Revenue 2020-2031
1.4.2 Global Pharmaceutical Unit Dose Package Sales 2020-2031
1.4.3 Global Pharmaceutical Unit Dose Package 麻豆原创 Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Pharmaceutical Unit Dose Package 麻豆原创 Competition by Manufacturers
2.1 Global Pharmaceutical Unit Dose Package Sales 麻豆原创 Share by Manufacturers (2020-2025)
2.2 Global Pharmaceutical Unit Dose Package Revenue 麻豆原创 Share by Manufacturers (2020-2025)
2.3 Global Pharmaceutical Unit Dose Package Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Pharmaceutical Unit Dose Package, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Pharmaceutical Unit Dose Package, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Pharmaceutical Unit Dose Package, Product Type & Application
2.7 Global Key Manufacturers of Pharmaceutical Unit Dose Package, Date of Enter into This Industry
2.8 Global Pharmaceutical Unit Dose Package 麻豆原创 Competitive Situation and Trends
2.8.1 Global Pharmaceutical Unit Dose Package 麻豆原创 Concentration Rate
2.8.2 The Global 5 and 10 Largest Pharmaceutical Unit Dose Package Players 麻豆原创 Share by Revenue
2.8.3 Global Pharmaceutical Unit Dose Package 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Pharmaceutical Unit Dose Package 麻豆原创 Scenario by Region
3.1 Global Pharmaceutical Unit Dose Package 麻豆原创 Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Pharmaceutical Unit Dose Package Sales by Region: 2020-2031
3.2.1 Global Pharmaceutical Unit Dose Package Sales by Region: 2020-2025
3.2.2 Global Pharmaceutical Unit Dose Package Sales by Region: 2026-2031
3.3 Global Pharmaceutical Unit Dose Package Revenue by Region: 2020-2031
3.3.1 Global Pharmaceutical Unit Dose Package Revenue by Region: 2020-2025
3.3.2 Global Pharmaceutical Unit Dose Package Revenue by Region: 2026-2031
3.4 North America Pharmaceutical Unit Dose Package 麻豆原创 Facts & Figures by Country
3.4.1 North America Pharmaceutical Unit Dose Package 麻豆原创 Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Pharmaceutical Unit Dose Package Sales by Country (2020-2031)
3.4.3 North America Pharmaceutical Unit Dose Package Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Pharmaceutical Unit Dose Package 麻豆原创 Facts & Figures by Country
3.5.1 Europe Pharmaceutical Unit Dose Package 麻豆原创 Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Pharmaceutical Unit Dose Package Sales by Country (2020-2031)
3.5.3 Europe Pharmaceutical Unit Dose Package Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Pharmaceutical Unit Dose Package 麻豆原创 Facts & Figures by Region
3.6.1 Asia Pacific Pharmaceutical Unit Dose Package 麻豆原创 Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Pharmaceutical Unit Dose Package Sales by Region (2020-2031)
3.6.3 Asia Pacific Pharmaceutical Unit Dose Package Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Pharmaceutical Unit Dose Package 麻豆原创 Facts & Figures by Country
3.7.1 Latin America Pharmaceutical Unit Dose Package 麻豆原创 Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Pharmaceutical Unit Dose Package Sales by Country (2020-2031)
3.7.3 Latin America Pharmaceutical Unit Dose Package Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Pharmaceutical Unit Dose Package 麻豆原创 Facts & Figures by Country
3.8.1 Middle East and Africa Pharmaceutical Unit Dose Package 麻豆原创 Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Pharmaceutical Unit Dose Package Sales by Country (2020-2031)
3.8.3 Middle East and Africa Pharmaceutical Unit Dose Package Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Pharmaceutical Unit Dose Package Sales by Type (2020-2031)
4.1.1 Global Pharmaceutical Unit Dose Package Sales by Type (2020-2025)
4.1.2 Global Pharmaceutical Unit Dose Package Sales by Type (2026-2031)
4.1.3 Global Pharmaceutical Unit Dose Package Sales 麻豆原创 Share by Type (2020-2031)
4.2 Global Pharmaceutical Unit Dose Package Revenue by Type (2020-2031)
4.2.1 Global Pharmaceutical Unit Dose Package Revenue by Type (2020-2025)
4.2.2 Global Pharmaceutical Unit Dose Package Revenue by Type (2026-2031)
4.2.3 Global Pharmaceutical Unit Dose Package Revenue 麻豆原创 Share by Type (2020-2031)
4.3 Global Pharmaceutical Unit Dose Package Price by Type (2020-2031)
5 Segment by Application
5.1 Global Pharmaceutical Unit Dose Package Sales by Application (2020-2031)
5.1.1 Global Pharmaceutical Unit Dose Package Sales by Application (2020-2025)
5.1.2 Global Pharmaceutical Unit Dose Package Sales by Application (2026-2031)
5.1.3 Global Pharmaceutical Unit Dose Package Sales 麻豆原创 Share by Application (2020-2031)
5.2 Global Pharmaceutical Unit Dose Package Revenue by Application (2020-2031)
5.2.1 Global Pharmaceutical Unit Dose Package Revenue by Application (2020-2025)
5.2.2 Global Pharmaceutical Unit Dose Package Revenue by Application (2026-2031)
5.2.3 Global Pharmaceutical Unit Dose Package Revenue 麻豆原创 Share by Application (2020-2031)
5.3 Global Pharmaceutical Unit Dose Package Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Amcor
6.1.1 Amcor Company Information
6.1.2 Amcor Description and Business Overview
6.1.3 Amcor Pharmaceutical Unit Dose Package Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Amcor Pharmaceutical Unit Dose Package Product Portfolio
6.1.5 Amcor Recent Developments/Updates
6.2 Constantia Flexibles
6.2.1 Constantia Flexibles Company Information
6.2.2 Constantia Flexibles Description and Business Overview
6.2.3 Constantia Flexibles Pharmaceutical Unit Dose Package Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Constantia Flexibles Pharmaceutical Unit Dose Package Product Portfolio
6.2.5 Constantia Flexibles Recent Developments/Updates
6.3 Kl枚ckner Pentaplast
6.3.1 Kl枚ckner Pentaplast Company Information
6.3.2 Kl枚ckner Pentaplast Description and Business Overview
6.3.3 Kl枚ckner Pentaplast Pharmaceutical Unit Dose Package Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Kl枚ckner Pentaplast Pharmaceutical Unit Dose Package Product Portfolio
6.3.5 Kl枚ckner Pentaplast Recent Developments/Updates
6.4 Bemis
6.4.1 Bemis Company Information
6.4.2 Bemis Description and Business Overview
6.4.3 Bemis Pharmaceutical Unit Dose Package Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Bemis Pharmaceutical Unit Dose Package Product Portfolio
6.4.5 Bemis Recent Developments/Updates
6.5 MeadWestvaco
6.5.1 MeadWestvaco Company Information
6.5.2 MeadWestvaco Description and Business Overview
6.5.3 MeadWestvaco Pharmaceutical Unit Dose Package Sales, Revenue and Gross Margin (2020-2025)
6.5.4 MeadWestvaco Pharmaceutical Unit Dose Package Product Portfolio
6.5.5 MeadWestvaco Recent Developments/Updates
6.6 Tekni-plex
6.6.1 Tekni-plex Company Information
6.6.2 Tekni-plex Description and Business Overview
6.6.3 Tekni-plex Pharmaceutical Unit Dose Package Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Tekni-plex Pharmaceutical Unit Dose Package Product Portfolio
6.6.5 Tekni-plex Recent Developments/Updates
6.7 Honeywell
6.7.1 Honeywell Company Information
6.7.2 Honeywell Description and Business Overview
6.7.3 Honeywell Pharmaceutical Unit Dose Package Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Honeywell Pharmaceutical Unit Dose Package Product Portfolio
6.7.5 Honeywell Recent Developments/Updates
6.8 CPH GROUP
6.8.1 CPH GROUP Company Information
6.8.2 CPH GROUP Description and Business Overview
6.8.3 CPH GROUP Pharmaceutical Unit Dose Package Sales, Revenue and Gross Margin (2020-2025)
6.8.4 CPH GROUP Pharmaceutical Unit Dose Package Product Portfolio
6.8.5 CPH GROUP Recent Developments/Updates
6.9 Shanghai Haishun
6.9.1 Shanghai Haishun Company Information
6.9.2 Shanghai Haishun Description and Business Overview
6.9.3 Shanghai Haishun Pharmaceutical Unit Dose Package Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Shanghai Haishun Pharmaceutical Unit Dose Package Product Portfolio
6.9.5 Shanghai Haishun Recent Developments/Updates
6.10 Bilcare
6.10.1 Bilcare Company Information
6.10.2 Bilcare Description and Business Overview
6.10.3 Bilcare Pharmaceutical Unit Dose Package Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Bilcare Pharmaceutical Unit Dose Package Product Portfolio
6.10.5 Bilcare Recent Developments/Updates
6.11 IPS Ariflex
6.11.1 IPS Ariflex Company Information
6.11.2 IPS Ariflex Description and Business Overview
6.11.3 IPS Ariflex Pharmaceutical Unit Dose Package Sales, Revenue and Gross Margin (2020-2025)
6.11.4 IPS Ariflex Pharmaceutical Unit Dose Package Product Portfolio
6.11.5 IPS Ariflex Recent Developments/Updates
6.12 Zhong jin
6.12.1 Zhong jin Company Information
6.12.2 Zhong jin Description and Business Overview
6.12.3 Zhong jin Pharmaceutical Unit Dose Package Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Zhong jin Pharmaceutical Unit Dose Package Product Portfolio
6.12.5 Zhong jin Recent Developments/Updates
6.13 Carcano Antonio
6.13.1 Carcano Antonio Company Information
6.13.2 Carcano Antonio Description and Business Overview
6.13.3 Carcano Antonio Pharmaceutical Unit Dose Package Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Carcano Antonio Pharmaceutical Unit Dose Package Product Portfolio
6.13.5 Carcano Antonio Recent Developments/Updates
6.14 Aluberg
6.14.1 Aluberg Company Information
6.14.2 Aluberg Description and Business Overview
6.14.3 Aluberg Pharmaceutical Unit Dose Package Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Aluberg Pharmaceutical Unit Dose Package Product Portfolio
6.14.5 Aluberg Recent Developments/Updates
6.15 Goldstonepack
6.15.1 Goldstonepack Company Information
6.15.2 Goldstonepack Description and Business Overview
6.15.3 Goldstonepack Pharmaceutical Unit Dose Package Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Goldstonepack Pharmaceutical Unit Dose Package Product Portfolio
6.15.5 Goldstonepack Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Pharmaceutical Unit Dose Package Industry Chain Analysis
7.2 Pharmaceutical Unit Dose Package Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Pharmaceutical Unit Dose Package Production Mode & Process Analysis
7.4 Pharmaceutical Unit Dose Package Sales and 麻豆原创ing
7.4.1 Pharmaceutical Unit Dose Package Sales Channels
7.4.2 Pharmaceutical Unit Dose Package Distributors
7.5 Pharmaceutical Unit Dose Package Customer Analysis
8 Pharmaceutical Unit Dose Package 麻豆原创 Dynamics
8.1 Pharmaceutical Unit Dose Package Industry Trends
8.2 Pharmaceutical Unit Dose Package 麻豆原创 Drivers
8.3 Pharmaceutical Unit Dose Package 麻豆原创 Challenges
8.4 Pharmaceutical Unit Dose Package 麻豆原创 Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 麻豆原创 Size Estimation
10.1.3 麻豆原创 Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Amcor
Constantia Flexibles
Kl枚ckner Pentaplast
Bemis
MeadWestvaco
Tekni-plex
Honeywell
CPH GROUP
Shanghai Haishun
Bilcare
IPS Ariflex
Zhong jin
Carcano Antonio
Aluberg
Goldstonepack
听
听
*If Applicable.
